Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1083P refers to a pseudogene derived from the U6 small nuclear RNA gene family; it is not a functional gene and does not encode a functional RNA or protein[1][2][6]. U6 small nuclear RNA (snRNA) itself is a critical component of the spliceosome complex responsible for pre-mRNA splicing in eukaryotes[3][5]. However, "RNU6-1083P" is classified as a pseudogene, meaning that it is a nonfunctional genomic DNA sequence similar to the functional U6 snRNA gene, but lacks the ability to contribute to normal cellular processes[1][2]. Pseudogenes such as RNU6-1083P typically arise through genomic duplication or retrotransposition and accumulate mutations that prevent them from being expressed or functioning like their parent gene[4]. There are no described therapeutic, diagnostic, or drug interaction roles for this pseudogene, and it should not be considered a true molecular or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1083, pseudogene (RNU6-1083P).